Rizatriptan benzoate orally disintegrating tablets are used to treat acute migraines in adults and children aged 6 to 17. It works by helping to narrow blood vessels in the brain, which can relieve headache pain. The recommended starting dose for adults is either 5 mg or 10 mg, and you can take a second dose 2 hours after the first if needed, but don't exceed 30 mg in one day. It's important to know that this medication should not be used if you have a history of heart problems. Additionally, if you're taking propranolol, you should only use the 5 mg dose and not exceed 15 mg in a day.
✦
Uses
- Acute treatment of migraine with aura in adults.
- Acute treatment of migraine without aura in adults.
- Acute treatment of migraine in pediatric patients aged 6 to 17.
◷
Dosage
Adults: Start with 5 mg or 10 mg for migraines.
Pediatric patients under 40 kg: 5 mg dose.
Pediatric patients 40 kg or more: 10 mg dose.
If migraine returns, a second dose may be taken 2 hours after the first.
Maximum daily dose is 30 mg for adults.
Always follow your doctor's specific instructions for your dose.
⚠
Side effects
Common
Fatiguedizzinessdry mouthnauseaChest painIncreased blood pressureRisk of serotonin syndromeRisk of myocardial ischemia or infarction
Serious
tightnessor pressure
🛑
Warnings
⚠ Important warnings
- Only use if diagnosed with migraine.
- Not for hemiplegic or basilar migraine.
- Not for migraine prevention.
- Use caution if taking propranolol.
- May cause medication overuse headache.
⇄
Drug interactions
- Propranololincreases rizatriptan levelsMonitor
- Ergot-containing drugsrisk of prolonged vasospasmCaution
- Other 5-HT1 agonistsrisk of additive effectsCaution
- MAO inhibitorsincreases rizatriptan levelsMonitor
- SSRIs/SNRIsrisk of serotonin syndrome.Caution
Ask about this drug
Answers pulled from the FDA label only.
Medical Disclaimer: This content is provided for informational and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before taking any medication.
Data Source: Publicly available drug labeling information from the U.S. Food and Drug Administration (FDA).
Data Source: Publicly available drug labeling information from the U.S. Food and Drug Administration (FDA).
MedDataTool